Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from West Pharmaceutical Services ( (WST) ) is now available.
West Pharmaceutical Services, Inc. held its 2026 Annual Meeting of Shareholders virtually on May 4, 2026, with 91.83% of outstanding common shares represented. Shareholders elected eleven directors to serve until the 2027 Annual Meeting, reaffirming the existing board’s composition and leadership structure.
Investors approved on an advisory basis the compensation of the company’s named executive officers and ratified PricewaterhouseCoopers LLP as independent auditor for the 2026 fiscal year. A shareholder proposal seeking an Independent Board Chair Policy was not approved, signaling continued investor support for West’s current governance model and board leadership framework.
The most recent analyst rating on (WST) stock is a Hold with a $310.00 price target. To see the full list of analyst forecasts on West Pharmaceutical Services stock, see the WST Stock Forecast page.
Spark’s Take on WST Stock
According to Spark, TipRanks’ AI Analyst, WST is a Outperform.
The score is driven primarily by strong financial quality (low leverage, resilient profitability) and a very positive earnings update (raised 2026 guidance, strong Q1 execution and margins, buyback). Offsetting factors include a premium valuation (P/E ~32.5 with a very low dividend yield) and technicals that look extended with overbought signals despite strong momentum.
To see Spark’s full report on WST stock, click here.
More about West Pharmaceutical Services
West Pharmaceutical Services, Inc. operates in the healthcare and pharmaceutical packaging industry, providing containment and delivery solutions for injectable medicines. The company focuses on supplying components and systems used by pharmaceutical and biotechnology firms to safely package, protect, and administer drug products in global markets.
Average Trading Volume: 946,852
Technical Sentiment Signal: Buy
Current Market Cap: $21.21B
For a thorough assessment of WST stock, go to TipRanks’ Stock Analysis page.